Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 16, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Diabetic Foot Ulcer
Interventions
DRUG

Xianglei Tangzu Gao

Active ingredients: Extracts of Plectranthus amboinicus and Centella Asiatica

OTHER

Vehicle Cream

Cream base of Xianglei Tangzu Gao

Trial Locations (16)

Unknown

RECRUITING

Jiangmen Central Hospital, Jiangmen

RECRUITING

The First Affiliated Hospital of Henan University of Science & Technology, Luoyang

RECRUITING

The First Affiliated Hospital of Soochow University, Suzhou

WITHDRAWN

The Second Affiliated Hospital of Soochow University, Suzhou

RECRUITING

Affiliated Hospital of Jiangsu University, Zhenjiang

RECRUITING

Shenyang Seventh People's Hospital (Shenyang Hospital of Integrated Traditional Chinese and Western Medicine), Shenyang

RECRUITING

The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an

RECRUITING

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

RECRUITING

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

RECRUITING

Nanfang Hospital, Guangzhou

RECRUITING

Southern Medical University Third Hospital, Guangzhou

RECRUITING

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

RECRUITING

Huadong Hospital Affiliated to Fudan University, Shanghai

RECRUITING

Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai

RECRUITING

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

RECRUITING

Shanghai TCM Integrated Hospital, Shanghai

Sponsors
All Listed Sponsors
lead

Oneness Biotech Co., Ltd.

INDUSTRY